Rick Wise
Stock Analyst at Stifel
(4.40)
# 323
Out of 4,876 analysts
237
Total ratings
64.77%
Success rate
11.51%
Average return
Main Sectors:
Stocks Rated by Rick Wise
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZBH Zimmer Biomet Holdings | Maintains: Buy | $138 → $115 | $91.46 | +25.74% | 15 | May 6, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $280 → $224 | $170.86 | +31.10% | 8 | May 2, 2025 | |
| CNMD CONMED | Downgrades: Hold | $75 → $55 | $52.17 | +5.42% | 11 | Apr 28, 2025 | |
| ABT Abbott Laboratories | Maintains: Buy | $135 → $145 | $134.38 | +7.90% | 20 | Apr 17, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Buy | $28 | $17.67 | +58.46% | 1 | Mar 31, 2025 | |
| KIDS OrthoPediatrics | Maintains: Buy | $40 → $32 | $21.44 | +49.25% | 6 | Mar 5, 2025 | |
| LIVN LivaNova | Maintains: Buy | $72 → $60 | $45.78 | +31.06% | 6 | Feb 26, 2025 | |
| AORT Artivion | Maintains: Buy | $33 → $30 | $31.19 | -3.82% | 6 | Feb 25, 2025 | |
| ATRC AtriCure | Maintains: Buy | $36 → $48 | $32.28 | +48.70% | 13 | Feb 13, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $115 → $120 | $106.53 | +12.64% | 17 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $75 → $90 | $78.21 | +15.07% | 23 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $400 → $440 | $393.55 | +11.80% | 16 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $170 → $155 | $152.41 | +1.70% | 6 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $525 → $610 | $533.71 | +14.29% | 17 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $170 → $190 | $168.21 | +12.95% | 14 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $38 | $30.39 | +25.04% | 8 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $7 → $8 | $5.75 | +39.13% | 8 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $16 | $2.61 | +513.03% | 4 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $82 | $75.46 | +8.67% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $102 | $74.38 | +37.13% | 2 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $85 → $87 | $86.02 | +1.14% | 11 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $9 → $12 | $5.92 | +102.70% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $59 → $75 | $82.57 | -9.17% | 1 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $17 → $24 | $18.94 | +26.72% | 7 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $390 → $90 | $18.96 | +374.81% | 4 | Oct 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $25 | $12.21 | +104.75% | 4 | Jun 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $103 → $112 | $56.77 | +97.29% | 5 | Oct 2, 2020 |
Zimmer Biomet Holdings
May 6, 2025
Maintains: Buy
Price Target: $138 → $115
Current: $91.46
Upside: +25.74%
Becton, Dickinson and Company
May 2, 2025
Maintains: Buy
Price Target: $280 → $224
Current: $170.86
Upside: +31.10%
CONMED
Apr 28, 2025
Downgrades: Hold
Price Target: $75 → $55
Current: $52.17
Upside: +5.42%
Abbott Laboratories
Apr 17, 2025
Maintains: Buy
Price Target: $135 → $145
Current: $134.38
Upside: +7.90%
Kestra Medical Technologies
Mar 31, 2025
Initiates: Buy
Price Target: $28
Current: $17.67
Upside: +58.46%
OrthoPediatrics
Mar 5, 2025
Maintains: Buy
Price Target: $40 → $32
Current: $21.44
Upside: +49.25%
LivaNova
Feb 26, 2025
Maintains: Buy
Price Target: $72 → $60
Current: $45.78
Upside: +31.06%
Artivion
Feb 25, 2025
Maintains: Buy
Price Target: $33 → $30
Current: $31.19
Upside: -3.82%
AtriCure
Feb 13, 2025
Maintains: Buy
Price Target: $36 → $48
Current: $32.28
Upside: +48.70%
Boston Scientific
Feb 10, 2025
Maintains: Buy
Price Target: $115 → $120
Current: $106.53
Upside: +12.64%
Jan 30, 2025
Upgrades: Buy
Price Target: $75 → $90
Current: $78.21
Upside: +15.07%
Jan 29, 2025
Maintains: Buy
Price Target: $400 → $440
Current: $393.55
Upside: +11.80%
Jan 23, 2025
Maintains: Hold
Price Target: $170 → $155
Current: $152.41
Upside: +1.70%
Dec 5, 2024
Maintains: Buy
Price Target: $525 → $610
Current: $533.71
Upside: +14.29%
Nov 22, 2024
Reiterates: Buy
Price Target: $170 → $190
Current: $168.21
Upside: +12.95%
Nov 11, 2024
Maintains: Buy
Price Target: $46 → $38
Current: $30.39
Upside: +25.04%
Nov 6, 2024
Maintains: Hold
Price Target: $7 → $8
Current: $5.75
Upside: +39.13%
Oct 31, 2024
Maintains: Buy
Price Target: $17 → $16
Current: $2.61
Upside: +513.03%
Oct 8, 2024
Initiates: Buy
Price Target: $82
Current: $75.46
Upside: +8.67%
Sep 30, 2024
Maintains: Buy
Price Target: $100 → $102
Current: $74.38
Upside: +37.13%
Aug 21, 2024
Maintains: Hold
Price Target: $85 → $87
Current: $86.02
Upside: +1.14%
Jul 16, 2024
Upgrades: Buy
Price Target: $9 → $12
Current: $5.92
Upside: +102.70%
Apr 26, 2024
Upgrades: Buy
Price Target: $59 → $75
Current: $82.57
Upside: -9.17%
Feb 5, 2024
Maintains: Hold
Price Target: $17 → $24
Current: $18.94
Upside: +26.72%
Oct 13, 2023
Maintains: Buy
Price Target: $390 → $90
Current: $18.96
Upside: +374.81%
Jun 21, 2023
Reiterates: Hold
Price Target: $25
Current: $12.21
Upside: +104.75%
Oct 2, 2020
Maintains: Hold
Price Target: $103 → $112
Current: $56.77
Upside: +97.29%